Onconetix, Inc. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$815K
Cost of Revenue
$182K
Gross Profit
$633K
R&D
$154K
SG&A
$7M
D&A
$15K
Operating Income
$-18M
EBITDA
$-18M
Interest Expense
$751K
Interest Income
$2
Other Income/Expense
$5M
Pretax Income
$-14M
Tax Provision
$525
Net Income
$-14M
Gross Margin
77.6%
Operating Margin
-2190.0%
Net Margin
-1721.0%
Effective Tax Rate
-0.0%
Deferred Tax Assets
$10K
Deferred Tax Liabilities
$1K
DTA Valuation Allowance
$20M
Tax Credit Carryforwards
$1M
NOL Carryforwards
$11M
ETR (Continuing Operations)
—
ETR Federal Statutory
21.0%
ETR State + Local (pp)
-2.6%
ETR Foreign Differential (pp)
-0.1%
Pension Net Periodic Cost
$-906K
Revenue YoY Variation
-67.7%
Income YoY Variation
68.4%